) The University of Colorado Comprehensive Cancer Center (UCCC) is the only NCI- designed comprehensive Cancer Center in the Rocky Mountain region which has a population of about 8 million. The goals are to: 1) contribute to the reduction and elimination of cancer as a human health problem through coordinated programs in basic, clinical, translational and population sciences and 2) provide the citizens of the Rocky Mountain region with state-of-the-art cancer research, clinical, prevention and control and education programs. There are 244 full and 82 associate members who participate in one or more of the UCCC's 10 program including Cell Biology, Molecular and Structural Biology, Immunology and Immunotherapy, Hormone Related Malignancies, Tobacco Related Malignancies, Developmental Therapeutics, Pediatric Oncology, Cancer Genetics, Carcinogenesis and Chemoprevention and Clinical and Community Cancer Prevention and Control. Over the past 5 years, programs were reorganized to foster collaborative and translational research by including elements of basic, clinical and population sciences into the programs and to respond to rapid changes in scientific technology. UCCC members' productivity has increased as documented by more grant funding (32%), by a phenomenal growth in accruals to clinical trials (>1000%) and by their publication record. Cancer focus also increased as shown by the increases in NCI and peer-reviewed cancer agency funding (36%), and the increase in cancer clinical trials noted above. The research of the members is supported by 15 shared core resources which include 4 new facilities (Gene Expression, NMR, Pharmacology, Survey Research), 9 cores with expanded services (Biostatistics, Clinical Investigations, Cytogenetics, Flow Cytometry, Laboratory Animals, Tissue Procurement, Radiological Sciences, Protein Microchemistry, and Transgenic/Knockout) and 2 cores with continued services utilized by increased number of members (DNA Sequencing and Tissue Culture/Monoclonal Antibody). Core usage has increased over the past 5 years as documented by number of members, units of use, and charge back fees generated (110% increase). We have emphasized new technologies in the creation and expansion of these services. The UCCC is a """"""""matrix"""""""" Center within the School of Medicine, but has members from all of the UCHSC schools and affiliated institutions. During the next 3 years the UCCC will relocate to the new Fitzsimons campus which will triple the available outpatient and clinical research space (Nov. 2000) and the basic research space (Nov. 2002) at a cost of more than $180 million.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-18
Application #
6855221
Study Section
Subcommittee G - Education (NCI)
Program Officer
Ciolino, Henry P
Project Start
1988-03-01
Project End
2006-01-31
Budget Start
2005-05-19
Budget End
2006-01-31
Support Year
18
Fiscal Year
2005
Total Cost
$3,562,737
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Maccini, Michael A; Westfall, Nicholas J; Van Bokhoven, Adrie et al. (2018) The effect of digital rectal exam on the 4Kscore for aggressive prostate cancer. Prostate 78:506-511
Ye, Haobin; Adane, Biniam; Khan, Nabilah et al. (2018) Subversion of Systemic Glucose Metabolism as a Mechanism to Support the Growth of Leukemia Cells. Cancer Cell 34:659-673.e6
Flannery, Patrick C; DeSisto, John A; Amani, Vladimir et al. (2018) Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma. Oncol Rep 39:455-464
Elder, Alan M; Tamburini, Beth A J; Crump, Lyndsey S et al. (2018) Semaphorin 7A Promotes Macrophage-Mediated Lymphatic Remodeling during Postpartum Mammary Gland Involution and in Breast Cancer. Cancer Res 78:6473-6485
Yue, Zongliang; Zheng, Qi; Neylon, Michael T et al. (2018) PAGER 2.0: an update to the pathway, annotated-list and gene-signature electronic repository for Human Network Biology. Nucleic Acids Res 46:D668-D676
Smith, Weston J; Tran, Huy; Griffin, James I et al. (2018) Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes. Biomaterials 161:57-68
Morgan, Michael J; Fitzwalter, Brent E; Owens, Charles R et al. (2018) Metastatic cells are preferentially vulnerable to lysosomal inhibition. Proc Natl Acad Sci U S A 115:E8479-E8488
Hartwick, Erik W; Costantino, David A; MacFadden, Andrea et al. (2018) Ribosome-induced RNA conformational changes in a viral 3'-UTR sense and regulate translation levels. Nat Commun 9:5074
Genova, Carlo; Socinski, Mark A; Hozak, Rebecca R et al. (2018) EGFR Gene Copy Number by FISH May Predict Outcome of Necitumumab in Squamous Lung Carcinomas: Analysis from the SQUIRE Study. J Thorac Oncol 13:228-236
Greer, Robert O; Eskendri, Jeffrey; Freedman, Paul et al. (2018) Assessment of biologically aggressive, recurrent glandular odontogenic cysts for mastermind-like 2 (MAML2) rearrangements: histopathologic and fluorescent in situ hybridization (FISH) findings in 11 cases. J Oral Pathol Med 47:192-197

Showing the most recent 10 out of 1634 publications